Cygnus Technologies, part of Maravai LifeSciences, is the biopharmaceutical industry’s partner in host cell protein (HCP) and other process-related impurity detection and analytics. In addition, Cygnus now provides innovative viral clearance solutions as well.
Cygnus helps companies developing therapeutic proteins, vaccines, antibodies, plasma derivatives and gene therapies to ensure the safety of biotherapeutics prior to human trials, regulatory approval and commercial release. Cygnus provides analytical tools and solutions delivering insights to improve bioprocess development for faster regulatory approval and better clinical outcomes.
—
DONGIL BIOTECH specializes and handles biotechnology -related products and is one of the leading companies in biopharmaceutical industry.
DONGIL BIOTECH handles biotechnology products in the market since 1998 when the enterprise was established. With a recognition of our value in biopharmaceutical industry, DONGIL BIOTECH has been constantly growing along with broad network based on a vision to provide the best quality product.
Having continued to grow over 25 years since founds in 1998, with many years of experiences in biopharmaceutical industry, we have dedicated to supply proven products to domestic market through quality control that meets the world international quality standard.
Currently, DONGIL BIOTECH has been supplying high quality products within Korea that are directly imported from the United States, Europe and etc. providing globally competitive products including Cell Culture related products, Test kit for Quality Control at Biopharmaceutical companies, HCP and Protein A impurity ELISA Kits, Antibody, Growth Factor, reagents and bulk reagents for production use. Raising its exclusive market position, DONGIL BIOTECH is committed to becoming a reliable company with high credibility sharing information with our end-users.